Cassady Schiller Wealth Management’s Vanguard Mid-Cap Value ETF VOE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$7.21M Buy
44,588
+2,355
+6% +$397K 2.65% 5
2024
Q3
$7.08M Buy
42,233
+1,939
+5% +$308K 2.59% 6
2024
Q2
$6.06M Buy
40,294
+1,929
+5% +$293K 2.46% 6
2024
Q1
$5.98M Buy
38,365
+4,292
+13% +$630K 2.67% 5
2023
Q4
$4.94M Buy
34,073
+1,177
+4% +$158K 2.48% 6
2023
Q3
$4.31M Buy
32,896
+1,336
+4% +$185K 2.39% 5
2023
Q2
$4.37M Buy
31,560
+426
+1% +$56.8K 2.37% 6
2023
Q1
$4.17M Buy
31,134
+1,498
+5% +$208K 1.96% 8
2022
Q4
$4.01M Buy
29,636
+2,306
+8% +$309K 2.46% 6
2022
Q3
$3.33M Buy
27,330
+37
+0.1% +$5.01K 1.92% 11
2022
Q2
$3.54M Sell
27,293
-131
-0.5% -$18.5K 1.86% 11
2022
Q1
$4.11M Buy
27,424
+3,150
+13% +$463K 1.98% 11
2021
Q4
$3.65M Buy
+24,274
New +$3.56M 2.2% 11

Other funds holding VOE

Cassady Schiller Wealth Management's VOE Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Vanguard Mid-Cap Value ETF (VOE) stake by 5.6% in Q4 2024, buying an estimated $397K and bringing the position to 44,588 shares worth $7.21M. The position accounts for 2.65% of the portfolio, ranked #5.

Cassady Schiller Wealth Management first reported a position in VOE in Q4 2021 and has held it in 13 quarters since. 1,110 funds tracked by Wall St. Rank hold VOE as of Q4 2024.

  • Cassady Schiller Wealth Management held 44,588 shares of Vanguard Mid-Cap Value ETF worth $7.21M as of Q4 2024.
  • Cassady Schiller Wealth Management bought 2,355 Vanguard Mid-Cap Value ETF shares in Q4 2024, an estimated $397K.
  • Vanguard Mid-Cap Value ETF made up 2.65% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #5 holding.
  • Cassady Schiller Wealth Management first reported a position in Vanguard Mid-Cap Value ETF in Q4 2021 and has held it in 13 quarters since.
  • 1,110 funds tracked by Wall St. Rank held Vanguard Mid-Cap Value ETF as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.